Issue 11, 2012

Diaryl ether derivatives as anticancer agents – a review

Abstract

This review article examines the diaryl ether scaffold found in natural products, related analogs and innovative molecules. It looks at encompassing synthesis, structure–activity relationships (SARs), and studies on biological action, namely in the context of anti-cancer activity. The aim of this review is to show that the diaryl ether scaffold is an invaluable structure for the design of anticancer drugs. It focuses essentially on work published from January 2000 to March 2012.

Graphical abstract: Diaryl ether derivatives as anticancer agents – a review

Article information

Article type
Review Article
Submitted
18 Jul 2012
Accepted
07 Sep 2012
First published
11 Sep 2012

Med. Chem. Commun., 2012,3, 1356-1372

Diaryl ether derivatives as anticancer agents – a review

F. Bedos-Belval, A. Rouch, C. Vanucci-Bacqué and M. Baltas, Med. Chem. Commun., 2012, 3, 1356 DOI: 10.1039/C2MD20199B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements